Compare it with other GLP-1 weight loss medications, or explore the vial format on the Zepbound vials page
OU749, a species-specific uncompetitive GGT inhibitor, exhibits low toxicity and a broad therapeutic window for humans
*Correspondence: Bharat Marwaha, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
S.DharmapuriG.SrivastavaA.et al (2017)
FIGURE 1 The prevalence of DED, which surged to as high as 61.0% during the COVID-19 pandemic (Ji et al., 2023), underscores the influence of increased exposure to visual display terminals and widespread mask usage during the pandemic, which likely exacerbated the condition by decreasing blink frequency and increasing thermal air currents over the ocular area, thus enhancing tear evaporation rates (Uwimana et al., 2022
CJC-1295 pharmacology: Human studies confirmed dose-dependent IGF-1 increases of 35-120%, sustained over the dosing period (Teichman et al., 2006)